Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) – Stock analysts at Roth Capital lifted their Q4 2025 earnings per share estimates for shares of Celsius in a research note issued on Wednesday, May 7th. Roth Capital analyst S. Mcgowan now forecasts that the company will earn $0.28 per share for the quarter, up from their prior estimate of $0.27. The consensus estimate for Celsius’ current full-year earnings is $0.89 per share. Roth Capital also issued estimates for Celsius’ Q3 2026 earnings at $0.31 EPS, Q4 2026 earnings at $0.36 EPS, Q1 2027 earnings at $0.33 EPS and FY2027 earnings at $1.57 EPS.
Celsius (NASDAQ:CELH – Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.02). The company had revenue of $329.28 million during the quarter, compared to the consensus estimate of $349.09 million. Celsius had a net margin of 10.70% and a return on equity of 51.89%. Celsius’s revenue for the quarter was down 7.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.27 earnings per share.
Check Out Our Latest Research Report on CELH
Celsius Stock Down 1.5 %
Shares of CELH stock opened at $35.24 on Thursday. Celsius has a 12-month low of $21.10 and a 12-month high of $98.85. The company has a market capitalization of $9.08 billion, a PE ratio of 80.09, a price-to-earnings-growth ratio of 2.90 and a beta of 1.65. The firm has a 50 day moving average price of $33.78 and a two-hundred day moving average price of $29.64.
Insider Transactions at Celsius
In related news, insider Paul H. Storey sold 10,188 shares of Celsius stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $25.77, for a total transaction of $262,544.76. Following the sale, the insider now directly owns 45,297 shares of the company’s stock, valued at approximately $1,167,303.69. The trade was a 18.36 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Joyce Russell sold 4,000 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total transaction of $113,880.00. Following the completion of the transaction, the director now directly owns 19,106 shares of the company’s stock, valued at approximately $543,947.82. The trade was a 17.31 % decrease in their position. The disclosure for this sale can be found here. 2.55% of the stock is owned by insiders.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of CELH. HM Payson & Co. grew its position in Celsius by 122.2% during the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company’s stock worth $26,000 after acquiring an additional 550 shares during the last quarter. Westside Investment Management Inc. acquired a new position in shares of Celsius in the first quarter valued at approximately $32,000. S.A. Mason LLC raised its holdings in Celsius by 100.0% in the 4th quarter. S.A. Mason LLC now owns 1,400 shares of the company’s stock valued at $37,000 after buying an additional 700 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its position in Celsius by 255.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company’s stock worth $37,000 after buying an additional 750 shares during the period. Finally, GAMMA Investing LLC grew its holdings in Celsius by 185.7% during the 4th quarter. GAMMA Investing LLC now owns 1,714 shares of the company’s stock worth $45,000 after acquiring an additional 1,114 shares during the last quarter. 60.95% of the stock is currently owned by institutional investors and hedge funds.
Celsius Company Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Read More
- Five stocks we like better than Celsius
- How to Effectively Use the MarketBeat Ratings Screener
- IBM’s AI Offensive: Assessing IBM’s Path to Renewed Growth
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Rockwell Automation: Tailwinds From Onshoring U.S. Production
- What Are Dividend Champions? How to Invest in the Champions
- Is Energy Transfer Undervalued or a Value Trap?
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.